Literature DB >> 25740705

New insights on biomarkers in systemic vasculitis.

Rodolfo Perez-Alamino1, Hernán Maldonado-Ficco.   

Abstract

The systemic vasculitis is a heterogeneous group of diseases characterized by the inflammation of blood vessels. The development of advanced diagnostic tests and genetic studies have resulted in greater improvement in our understanding of vasculitis pathogenesis and thus in the development of newer therapies. However, there is still an unmet need in the management of systemic vasculitis, focused on developing of new biomarkers that would enable distinction between active disease from damage or infection and predict treatment response and prognosis.

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25740705     DOI： 10.1007/s11926-015-0497-0

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN： 1523-3774            Impact factor:   4.592


  51 in total

1.  Value of ANCA measurements during remission to predict a relapse of ANCA-associated vasculitis--a meta-analysis.

Authors:  Gunnar Tomasson; Peter C Grayson; Alfred D Mahr; Michael Lavalley; Peter A Merkel
Journal:  Rheumatology (Oxford)       Date:  2011-10-29       Impact factor: 7.580

2.  Sensitive assessment of activity of Takayasu's arteritis by pentraxin3, a new biomarker.

Authors:  Takashi Ishihara; Go Haraguchi; Tetsuo Kamiishi; Daisuke Tezuka; Hiroshi Inagaki; Mitsuaki Isobe
Journal:  J Am Coll Cardiol       Date:  2011-04-19       Impact factor: 24.094

3.  Selective up-regulation of the soluble pattern-recognition receptor pentraxin 3 and of vascular endothelial growth factor in giant cell arteritis: relevance for recent optic nerve ischemia.

Authors:  Mattia Baldini; Norma Maugeri; Giuseppe A Ramirez; Chiara Giacomassi; Alessandra Castiglioni; Sergio Prieto-González; Marc Corbera-Bellalta; Gabriele Di Comite; Ilenia Papa; Giacomo Dell'antonio; Enrico Ammirati; Ivan Cuccovillo; Viviana Vecchio; Alberto Mantovani; Patrizia Rovere-Querini; Maria Grazia Sabbadini; Maria C Cid; Angelo A Manfredi
Journal:  Arthritis Rheum       Date:  2012-03

4.  Rituximab for remission induction and maintenance in refractory granulomatosis with polyangiitis (Wegener's): ten-year experience at a single center.

Authors:  Rodrigo Cartin-Ceba; Jason M Golbin; Karina A Keogh; Tobias Peikert; Marta Sánchez-Menéndez; Steven R Ytterberg; Fernando C Fervenza; Ulrich Specks
Journal:  Arthritis Rheum       Date:  2012-11

5.  Use of highly sensitive C-reactive protein for followup of Wegener's granulomatosis.

Authors:  Anna-Isabelle Kälsch; Elena Csernok; Dominik Münch; Rainer Birck; Benito A Yard; Wolfgang Gross; Thorsten Kälsch; Wilhelm H Schmitt
Journal:  J Rheumatol       Date:  2010-08-17       Impact factor: 4.666

6.  Correlation of interleukin-6 production and disease activity in polymyalgia rheumatica and giant cell arteritis.

Authors:  N E Roche; J W Fulbright; A D Wagner; G G Hunder; J J Goronzy; C M Weyand
Journal:  Arthritis Rheum       Date:  1993-09

7.  Positron emission tomography in the diagnosis and management of giant cell arteritis.

Authors:  Michael L Szmodis; Richard C Reba; David Earl-Graef
Journal:  Headache       Date:  2007-09       Impact factor: 5.887

8.  Cogan's syndrome: anti-Hsp70 antibodies are a serological marker in the typical form.

Authors:  Chiara Bonaguri; Jelka Orsoni; Annalisa Russo; Pierangela Rubino; Salvatore Bacciu; Giuseppe Lippi; Alessandra Melegari; Laura Zavota; Stella Ghirardini; Paolo Mora
Journal:  Isr Med Assoc J       Date:  2014-05       Impact factor: 0.892

9.  2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides.

Authors:  J C Jennette; R J Falk; P A Bacon; N Basu; M C Cid; F Ferrario; L F Flores-Suarez; W L Gross; L Guillevin; E C Hagen; G S Hoffman; D R Jayne; C G M Kallenberg; P Lamprecht; C A Langford; R A Luqmani; A D Mahr; E L Matteson; P A Merkel; S Ozen; C D Pusey; N Rasmussen; A J Rees; D G I Scott; U Specks; J H Stone; K Takahashi; R A Watts
Journal:  Arthritis Rheum       Date:  2013-01

10.  Is serum HMGB1 a biomarker in ANCA-associated vasculitis?

Authors:  Alexandre de Souza; Johanna Westra; Johan Bijzet; Pieter C Limburg; Coen A Stegeman; Marc Bijl; Cees G M Kallenberg
Journal:  Arthritis Res Ther       Date:  2013       Impact factor: 5.156
View more
  2 in total

1.  Prevalence of overlap of antineutrophil cytoplasmic antibody associated vasculitis with systemic autoimmune diseases: an unrecognized example of poliautoimmunity.

Authors:  Eduardo Martín-Nares; Diego Zuñiga-Tamayo; Andrea Hinojosa-Azaola
Journal:  Clin Rheumatol       Date:  2018-07-14       Impact factor: 2.980

2.  Assessment of the association between red blood cell distribution width and disease activity in patients with systemic vasculitis.

Authors:  Jing Hong; Bin Zhu; Xintian Cai; Shanshan Liu; Shasha Liu; Qing Zhu; Xiayire Aierken; Ayiguzaili Aihemaiti; Ting Wu; Nanfang Li
Journal:  Exp Ther Med       Date:  2021-05-02       Impact factor: 2.447
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.